Successful Topical Treatment of Sorafenib-Induced Hand–Foot Skin Reaction in a Child with Hepatocellular Carcinoma |
| |
Authors: | MATTHIAS HÜ TTEN,M.D.,LISA LASSAY,M.D.,BERNHARDT SACHS,M.D.,&dagger ,PETER DEUTZ,M.D.,ROLAND MERTENS,M.D.,JENS MALTE BARON,M.D.,&Dagger ,HANS-FRIEDRICH MERK,M.D.,&Dagger HAGEN OTT,M.D.,&Dagger |
| |
Affiliation: | Departments of Pediatrics and Adolescent Medicine;and Dermatology and Allergology, RWTH Aachen University Hospital, Aachen, Germany;, and Federal Institute for Drugs and Medical Devices, Bonn, Germany |
| |
Abstract: | Abstract: Orally active kinase inhibitors such as Sorafenib are known to elicit cutaneous side effects in the majority of adult patients, whereas specific cutaneous complications of this agent have not been described in children so far. We here present the first pediatric case of Sorafenib-induced hand-foot-skin reaction and its successful topical therapy facilitating continuation of kinase inhibitor treatment. |
| |
Keywords: | |
|
|